A feasibility study of a mobile app to treat insomnia.


Journal

Translational behavioral medicine
ISSN: 1613-9860
Titre abrégé: Transl Behav Med
Pays: England
ID NLM: 101554668

Informations de publication

Date de publication:
16 03 2021
Historique:
pubmed: 1 4 2020
medline: 19 8 2021
entrez: 1 4 2020
Statut: ppublish

Résumé

Insomnia is a major public health concern. Sleep restriction therapy (SRT) is an effective behavioral treatment but its delivery is impeded by a shortage of trained clinicians. We developed a mobile app delivering SRT to individuals with insomnia. This feasibility study employed a mixed-methods design to examine the engagement, acceptability, and potential efficacy of the mobile app. Fifteen participants diagnosed with insomnia disorder used the mobile app synchronized with a wearable device for 3 weeks. Those who persisted with the study (n = 12) found the mobile app to be highly acceptable and engaging, logging on average 19 nightly sleep diary entries across the 21 day period. Significant improvements were observed for sleep measures (insomnia severity and sleep efficiency) and daytime symptoms (fatigue and sleepiness). The results suggest that a mobile app delivering SRT to individuals with insomnia is engaging, acceptable, and potentially efficacious. Further, a full-scale effectiveness study is warranted.

Identifiants

pubmed: 32227087
pii: 5813538
doi: 10.1093/tbm/ibaa019
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

604-612

Informations de copyright

© Society of Behavioral Medicine 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Melissa Aji (M)

Brain and Mind Centre, The University of Sydney, Camperdown, NSW, Australia.

Nick Glozier (N)

Brain and Mind Centre, The University of Sydney, Camperdown, NSW, Australia.
Faculty of Medicine and Health, Central Clinical School, The University of Sydney, Sydney, NSW, Australia.

Delwyn Bartlett (D)

Faculty of Medicine and Health, Central Clinical School, The University of Sydney, Sydney, NSW, Australia.
CIRUS, Centre for Sleep and Chronobiology, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW, Australia.

Dorian Peters (D)

School of Electrical and Information Engineering, The University of Sydney, Sydney, NSW, Australia.

Rafael A Calvo (RA)

Dyson School of Design Engineering, Imperial College, London, UK.

Yizhong Zheng (Y)

CIRUS, Centre for Sleep and Chronobiology, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW, Australia.

Ronald Grunstein (R)

CIRUS, Centre for Sleep and Chronobiology, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW, Australia.
Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Sydney, Australia.

Christopher Gordon (C)

CIRUS, Centre for Sleep and Chronobiology, Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW, Australia.
Susan Wakil School of Nursing, University of Sydney, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH